Literature DB >> 9305182

Ex vivo lung model of pig-to-human hyperacute xenograft rejection.

P Macchiarini1, G M Mazmanian, R Oriol, V de Montpreville, E Dulmet, S Fattal, J M Libert, S Doubine, D Nochy, R Rieben, P Dartevelle.   

Abstract

OBJECTIVE: Our objective was to study lung hyperacute rejection in the pig-to-human xenotransplantation combination.
METHODS: Pig lungs were harvested and continuously ventilated and perfused ex vivo, using a neonatal oxygenating system, with either xenogeneic unmodified human blood (n = 6) or autogeneic pig blood (n = 6).
RESULTS: Autoperfused lungs displayed normal hemodynamics, oxygen extraction (arteriovenous oxygen difference), and histologic characteristics throughout the 3-hour study period. By contrast, xenoperfused lungs displayed, within 30 minutes, severe pulmonary hypertension and abolishment of arteriovenous oxygen difference culminating in massive pulmonary edema, hemorrhage, and lung failure after 115 +/- 44.2 minutes of reperfusion. Within 30 minutes, the human blood showed a significant drop of anti-alpha Gal immunoglobulin M and G xenoreactive antibodies (enzyme-linked immunosorbent assay) and complement activity, consumption of clotting factors, and hemolysis; total circulating human immunoglobulins remained substantially normal. Histologically, lungs perfused with human blood were congestive and showed alveolar edema and hemorrhage and multiple fibrin and platelet thrombi obstructing the small pulmonary vessels (arterioles, capillaries, and venules) but not large (segmental or lobar) pulmonary vessels. On immunohistologic examination, deposits of human immunoglobulin M and complement (C1q and C3) proteins were observed on the alveolar capillaries.
CONCLUSIONS: This pig-to-human xenograft model suggests that the pig lung perfused with human blood has an early and violent hyperacute rejection that results in irreversible pulmonary dysfunction and failure within approximately 150 minutes of reperfusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305182     DOI: 10.1016/S0022-5223(97)70175-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

Review 2.  Lung xenotransplantation: recent progress and current status.

Authors:  Donald G Harris; Kevin J Quinn; Siamak Dahi; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-07-05       Impact factor: 3.907

3.  Xenogeneic lung transplantation models.

Authors:  Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson
Journal:  Methods Mol Biol       Date:  2012

4.  Human erythrocyte fragmentation during ex-vivo pig organ perfusion.

Authors:  Zahra A Habibabady; Selin Sendil; Felix Ellett; Franziska Pollok; Gabriela F Elias; Beth M French; Wenji Sun; Gheorghe Braileanu; Lars Burdorf; Daniel Irimia; Richard N Pierson; Agnes M Azimzadeh
Journal:  Xenotransplantation       Date:  2022-02-02       Impact factor: 3.907

5.  Effect of hyperkalemia and hemolysis caused by hyperacute rejection on cardiac function in pig to human ex vivo xenogeneic cardiac perfusion model.

Authors:  Jun Seok Kim; Hak-Mo Lee; Byoung Chol Oh; Hong-Gook Lim; Jeong Ryul Lee
Journal:  Korean Circ J       Date:  2011-03-31       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.